CVE-2017-17678 Cross-site scripting in n/a
A DOM-based cross-site scripting vulnerability in BMC Remedy Mid Tier allows attackers to inject malicious scripts into web pages viewed by other users.
- Exploited in the wild
- Not known
- Login needed
- Not needed
- Attackable
- Over the internet
- Victim action needed
- A user has to click or open something
- Fix
- None listed
What is CVE-2017-17678?
CVE-2017-17678 is a medium-severity cross-site scripting vulnerability in n/a, published on 19 May 2021. An attacker can exploit it over the internet without logging in, and only if a user opens a file or follows a link.
Official description
BMC Remedy Mid Tier 9.1SP3 is affected by cross-site scripting (XSS). A DOM-based cross-site scripting vulnerability was discovered in a legacy utility.
Weakness: CWE-79
Which versions are affected by CVE-2017-17678?
It affects 1 product.
Products include Bmc Remedy Mid-Tier.
How do I fix CVE-2017-17678?
No fix has been published for CVE-2017-17678 yet. Limit exposure of the affected software until one is available.
Escape output for the context it lands in and set a strict Content Security Policy. Upgrading the affected component is the real fix. More about Cross-site scripting.
Is CVE-2017-17678 being exploited?
There is no known exploitation of CVE-2017-17678 in the wild and no public exploit code.
Other vulnerabilities in n/a
Sources
Also known as GHSA-w2cx-4cp9-hmm4.